Can you use REDCap for industry-sponsored (commercial) trials?

REDCap is distributed under terms published by the consortium that develops it. As we read the consortium's public material, the licence is intended for not-for-profit institutions and other non-commercial organisations, and software access is organised around institutional partners rather than individual sales to companies. Because licence terms are legal documents that change, treat that sentence as a pointer, not a ruling: read the current terms on the consortium's website, and ask your institution's REDCap administrator how they apply to your situation.

The practical consequence for sponsors is that the person who can answer is rarely the study team. If you are a for-profit biotech, the question is whether any institution would be entitled to provide you an instance at all. If you are an academic investigator running a study funded or supplied by a company, the question is whether the arrangement is within what your institution's licence covers. Neither is a matter for a web page. Put the question to the institution's administrator and its legal or research contracts office, and keep the written answer in the study master file.

Suppose the licence question is settled. A commercial sponsor still carries obligations that an academic investigator may not: it must be able to show that the system used for regulated data is fit for purpose. That means validation evidence for your intended use, documented audit trail and signature controls, controlled access for monitors, auditors and statisticians, and procedures for upgrades and incidents. The REDCap Part 11 page lists the documents to request from a hosting institution, and the computer system validation guide explains how validation is scoped to intended use.

Hosting matters too. If an institution runs the instance, your study lives alongside others on infrastructure you do not control, on that institution's upgrade schedule. That can be fine; it should be a decision, not a surprise. Capture's equivalent is simpler to state: a hosted platform in the EU (Frankfurt) or the USA (N. Virginia), with row-level security between studies, role-based access, and documentation to support sponsor validation for enterprise customers.

Data ownership and exit deserve their own line in any agreement. Ask what happens to the data, the audit trail and the configuration if the arrangement ends, in what format they can be exported, and for how long records remain retrievable. Regulators expect records to stay readable for the required retention period, and a sponsor that cannot get its audit trail out of someone else's system has a problem at exactly the wrong moment.

Finally, cost. Where an institution provides REDCap at no licence fee, the sponsor's true cost may still include the institution's service charges, validation work and staff time. Fill in the REDCap true-cost worksheet with real numbers before comparing with a hosted EDC.

If REDCap is not available to you, or the answer is unclear and your timeline is not, the alternative is a platform you can start on without anyone's permission. Capture is a self-serve, all-in-one clinical trial platform: EDC, eCRF builder, ePRO, eConsent, randomisation and safety reporting in one system with one audit trail, suitable for Phase 1, 2 and 3. You build the study yourself, or upload a protocol and let the AI draft visits and forms for your review, and test everything in the sandbox before paying.

For commercial teams the useful details are contractual and operational. There is no setup fee, no per-site fee and no per-seat licence, and protocol amendments are made by your own study team without change orders. Sites join by QR code or invitation, monitors get role-based access, and every record carries a field-level audit trail. See clinical trial software for startup biotech and how to choose an EDC system for the wider evaluation, and the REDCap alternatives page for neutral comparison criteria.

If you already have a design in REDCap, for example from an academic collaborator, how to migrate from REDCap shows how to rebuild it quickly from a data dictionary export. The full feature-by-feature view is on the Capture vs REDCap comparison.